Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Rona M MacKie Department of Public Health, University of Glasgow,
Glasgow G12 8RZ Correspondence to R M MacKie
R.M.Mackie{at}clinmed.gla.ac.uk
The incidence of primary cutaneous malignant melanoma
continues to rise,1 coinciding with narrower excision
margins of normal skin being recommended around primary
melanomas.
2 3
The bulk of surgery for primary melanoma is
now done on an outpatient basis under local anaesthesia. This change
has occurred at a time when training in dermatological surgery has
developed, leading to a much higher proportion of excisions of primary
melanoma being done by dermatologists. In 1979 in the west of Scotland
only 3% of all primary melanomas were removed by dermatologists. By
1998 this figure had risen to 40%. Plastic surgeons now excise 26% of
primary melanomas compared with 65% 20 years ago, and general surgeons
excise 34% compared with 32%.
We aimed to establish if the change in type of surgeon removing primary
cutaneous malignant melanoma has affected the prognosis, and also
whether any evidence exists for a specialist treatment effect such as
has been observed for breast cancers, with better outcomes for surgeons
carrying out breast cancer surgery regularly.4
| |
Participants, methods, and results |
|---|
|
|
|---|
We identified 4159 melanoma patients from the files of the Scottish melanoma group. All patients had had their primary melanoma removed between 1979 and 1998. We divided the surgeons performing the definitive excision of the primary melanoma into dermatological, plastic surgery, or general surgery training. We recorded age, sex, tumour thickness, presence of ulceration, and maximum diameter of the primary tumour and noted mortality and cause of death up to 1998. We also looked at the effect within the three surgical groups of treating up to six or more than six primary melanomas annually.
An average of 10 years' follow up information was available for
all patients. To test for an association between tumour thickness and
type of surgical experience we used the
2 statistic for
trend, aggregated over the period of diagnosis. We used the Cox
proportional hazards model to compare the survival of patients in
relation to surgical experience,5 with adjustment for
thickness, ulceration, and maximum diameter of tumour and sex, age, and
deprivation category of patients.
The table shows the division of patients by tumour thickness, ulceration, maximum diameter of primary melanoma, and outcome by surgical training. Dermatologists treated a significantly higher proportion of thin melanomas (P<0.001). The proportion of ulcerated melanomas was higher in the plastic surgery group than in the dermatological group (P<0.001) and higher in the general surgical group than the plastic surgery group (P<0.001).
After adjustment for thickness, the best outcome was in the
dermatological surgeon treatment group (P=0.008). Statistical significance was lost when adjustment was made for ulceration and then
for maximum diameter. We found no evidence that surgeons in any of the
three categories who performed more than six primary melanoma excisions
annually had better outcomes than those who performed fewer excisions.
| |
Comment |
|---|
|
|
|---|
Survival of melanoma patients does not depend on the surgical
background of the person removing the primary tumour. The object of
this study was to provide an evidence base for primary care guidelines
on appropriate specialist referral. The data show that the growth in
dermatological surgeons excising primary melanomas has had no adverse
affect on patient outcome. We found no evidence that any type of
surgeon performing excisions of primary melanomas regularly had a
better outcome than those who carried out fewer excisions, possibly
because wide local excision is a relatively simple procedure. We
therefore provide an evidence base to recommend referral of suspected
primary melanomas to the dermatological, plastic surgery, or general
surgical service with the shortest surgical waiting time.
| |
Acknowledgments |
|---|
Contributors: RMM collected the data, wrote the paper, and is the guarantor for the study. CAB and DJH analysed the data.
| |
Footnotes |
|---|
Funding: The Scottish Melanoma Group is funded by NHS Scotland. RMM receives financial support from the Leverhulme Trust.
Conflicts of interest: None declared.
| |
References |
|---|
|
|
|---|
| 1. |
MacKie RM, Hole DJ, Hunter JAA, Rankin R, Evans A, McLaren K, et al.
Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality 1979-94.
BMJ
1997;
315:
1117-1121 |
| 2. | Veronesi U, Cascinelli N, Adamus J, Balch C, Bandiera D, Barchuk A, et al. Thin stage I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3 cm. N Engl J Med 1988; 318: 1159-1162[Abstract]. |
| 3. | Balch CM, Urist MM, Karakousis CP, Smith TJ, Temple WJ, Drzewiecki K, et al. Efficacy of 2-cm surgical margins for intermediate thickness melanomas (1 to 4 mm): Results of a multi-institutional randomized surgical trial. Ann Surg 1993; 218: 262-268[Web of Science][Medline]. |
| 4. | Sainsbury R, Haward B, Rider L, Johnston C, Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 1995; 345: 1265-1270[CrossRef][Web of Science][Medline]. |
| 5. | Cox DR. Regression models and life tables. J R Stat Soc (B) 1972; 34: 187-220. |
(Accepted 17 April 2002)
Read all Rapid Responses